ClinicalTrials.Veeva

Menu

Lung Clearance Index and Lung Allograft Dysfunction

University of Zurich (UZH) logo

University of Zurich (UZH)

Status

Withdrawn

Conditions

Lung Transplantation
Chronic Lung Allograft Dysfunction
Rejection Lung Transplant

Treatments

Other: Early detection of CLAD by Lung Clearance Index (LCI)

Study type

Observational

Funder types

Other

Identifiers

NCT03850002
2018-02174

Details and patient eligibility

About

The aim of this project is to evaluate the ability of the lung clearance index (LCI) to detect early chronic lung allograft failure (CLAD) in adult lung transplant recipients over a period of 3 years.

Full description

This single center study consists of three parts:

  1. Characterisation of the Zurich lung transplant cohort regarding CLAD status and pulmonary function impairment (cross-sectional, study part I)
  2. Evaluation of test-retest reliability of LCI in 20 clinically stable lung transplant recipients during three consecutive study visits (study part II)
  3. Prospective cohort study to test the ability of LCI to detect early CLAD in patients without prior CLAD (study part III)

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male and female lung transplant recipients
  • Written informed consent by the participant after information about the research project

Exclusion criteria

  • Any contraindication to perform pulmonary function tests (e.g., persistent pneumothorax)
  • Acute airway infection
  • Chronic infection due to Burkholderia spp and nontuberculosis mykobacteria NTM

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems